Biogen Beats, Tecfidera Continues to Fly
Long Ideas - Biogen Idec (BIIB) on Monday reported third quarter revenue of $1.8 billion, an increase of 32% from last year’s third quarter, and earnings of $2.05 … Continue Reading
Read nowMust Read
Obesity & PD-1: History Doesn’t Repeat But It Rhymes
The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical Submits 510(k) for Insulin Patch Pump
Modular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLatest Posts
Our Top Stories In Healthcare This Week
Recap - Medivation (MDVN) announced on Tuesday morning that the Phase III PREVAIL study, testing Xtandi (enzalutamide) in chemotherapy-naive patients with advanced prostate cancer, was stopped early … Continue Reading
Read nowWhat Shutdown? Illumina Rises Above the Noise
Long Ideas - Shares of Illumina (ILMN) have risen over 85% since our in-depth November 1, 2012 initiation of coverage, and for good reason: the company has, for … Continue Reading
Read nowZiopharm Secondary Prices At a Sharp Discount
Most Popular - On Thursday morning, Ziopharm Oncology (ZIOP) priced its recently announced secondary offering at $3.50 per share, a 30% discount to ZIOP’s $4.93 closing price on … Continue Reading
Read nowEnanta Pharmaceuticals: Holding Ahead of Some Key Events
Long Ideas - Since our July 24 report on Enanta Pharmaceuticals (ENTA), shares of the HCV company have risen over 15%, even after accounting for the sell-off in … Continue Reading
Read nowMedivation Chalks Up a Win but Market Hesitates
Long Ideas - Medivation (MDVN) announced on Tuesday morning that the Phase III PREVAIL study, testing Xtandi (enzalutamide) in chemotherapy-naive patients with advanced prostate cancer, was stopped early … Continue Reading
Read nowEveryone’s Piling Back Into Equities: Here’s Where PropThink is Involved
Long Ideas - Tekmira Pharmaceuticals (TKMR) announced a secondary offering on Wednesday and priced the deal before Thursday’s open. Tekmira is selling 3,750,000 common stock at a price … Continue Reading
Read now